A5086163582- Endometrial and Cervical Cancer Treatments
- MRI in cancer diagnosis
- Radiomics and Machine Learning in Medical Imaging
- Ovarian cancer diagnosis and treatment
- Cervical Cancer and HPV Research
- Colorectal and Anal Carcinomas
- Climate variability and models
- Management of metastatic bone disease
- Advanced MRI Techniques and Applications
Zuyderland Medisch Centrum
2024
Maastricht University Medical Centre
2015-2019
Maastricht University
2019
University Medical Center
2019
Abstract Objectives Imaging is increasingly used to assess lymph node involvement in clinically early-stage cervical cancer. This retrospective study aimed evaluate the diagnostic accuracy of MRI, CT, and [ 18 F]FDG-PET-CT. Methods Women with International Federation Gynaecology Obstetrics (FIGO) 2009 stage IA2-IIA cancer pretreatment imaging between 2017 were selected from Netherlands Cancer Registry. Patient-based region-based (i.e. pelvic common iliac) nodal status was extracted radiology...
Advanced stage cervical cancer is primarily treated by radiotherapy. Local tumor control a prerequisite for cure. Imaging after treatment controversial. Positron emission tomography (PET) combined with computer (PET-CT) shows great promise detecting metastases. On the other hand, magnetic resonance imaging (MRI) superior in depicting anatomical details. The combination of PET-MRI could result more accurate evaluation outcome. aim this pilot study to share our initial experience response...
For cervical carcinoma, the presence of persistent disease after radiotherapy (RT) is a significant predictor for survival. To date, no standard protocol available to evaluate response. This study was performed assess magnetic resonance imaging (MRI) local residual during and RT Federation Gynecology Obstetrics (FIGO) stage Ib1-IVa cancer.Forty-two patients were included. Patients underwent MRI before external beam RT, at final intracavitary brachytherapy (BCT) 2-3 months completion RT. Two...
Cervical cancer is associated with a high yearly mortality. The presence of persistent disease after radiotherapy significant predictor patient survival. aim our study was to assess if tumor volume regression measured MR imaging at the time brachytherapy can discriminate between patients who eventually will achieve complete response from those not. second objective evaluate whether predicts overall treatment failure.MRI evaluated quantitatively in 35 patients; by means volumetry on...